Summer Fresh® launches Pickled Veggies made with apple cider vinegar, bringing bold flavour, crunch and convenient veggies to everyday meals.

Originally published via Source Article.

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Originally published via Source Article.

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Originally published via Source Article.

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Originally published via Source Article.

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Originally published via Source Article.

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

Originally published via Source Article.

AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).

Originally published via Source Article.

AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).

Originally published via Source Article.

AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).

Originally published via Source Article.

AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).

Originally published via Source Article.